Edgewise Therapeutics, Inc. (EWTX) insider trading.
In Q3 2026, insiders at Edgewise Therapeutics, Inc. reported 34 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 21 sales worth $9.8M.
- Transactions
- 34
- Purchases (P)
- 0
- Sales (S)
- 21
- Net shares, P minus S
- -243,429
- Insiders
- 6
- Last filed
- 2026-08-14
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Russell Alan J | Director, Officer · Chief Scientific Officer | 9 | 0 | 5 |
| Donovan Joanne M. | Officer · CMO | 7 | 0 | 5 |
| Moore John R | Officer · General Counsel | 6 | 0 | 4 |
| Derakhshan Behrad | Officer · Chief Business Officer | 6 | 0 | 4 |
| Koch Kevin | Director, Officer · President and CEO | 5 | 0 | 3 |
| Fox Jonathan C | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-13 | Donovan Joanne M. | S (D) | 2,919 | $43.41 | 8,625 | Form 4 |
| 2026-08-12 | Koch Kevin | S (D) | 8,276 | $43.66 | 53,401 | Form 4 |
| 2026-08-12 | Koch Kevin | S (D) | 8,782 | $43.64 | 61,677 | Form 4 |
| 2026-08-12 | Koch Kevin | M (A) | 21,875 | $0 | 70,459 | Form 4 |
| 2026-08-12 | Koch Kevin | M (A) | 17,969 | $0 | 48,584 | Form 4 |
| 2026-08-12 | Koch Kevin | S (D) | 913 | $44.33 | 52,488 | Form 4 |
| 2026-08-12 | Moore John R | S (D) | 2,439 | $43.81 | 20,274 | Form 4 |
| 2026-08-12 | Moore John R | M (A) | 6,718 | $0 | 22,713 | Form 4 |
| 2026-08-12 | Moore John R | S (D) | 59 | $44.41 | 20,215 | Form 4 |
| 2026-08-12 | Moore John R | S (D) | 99 | $44.5 | 20,116 | Form 4 |
| 2026-08-12 | Moore John R | S (D) | 2,419 | $43.8 | 17,697 | Form 4 |
| 2026-08-12 | Moore John R | M (A) | 5,781 | $0 | 15,995 | Form 4 |
| 2026-08-12 | Donovan Joanne M. | S (D) | 800 | $44.52 | 11,544 | Form 4 |
| 2026-08-12 | Donovan Joanne M. | S (D) | 104 | $44.43 | 12,344 | Form 4 |
| 2026-08-12 | Donovan Joanne M. | S (D) | 2,779 | $43.71 | 12,448 | Form 4 |
| 2026-08-12 | Donovan Joanne M. | S (D) | 2,839 | $43.78 | 15,227 | Form 4 |
| 2026-08-12 | Donovan Joanne M. | M (A) | 7,031 | $0 | 18,066 | Form 4 |
| 2026-08-12 | Donovan Joanne M. | M (A) | 5,781 | $0 | 11,035 | Form 4 |
| 2026-08-12 | Derakhshan Behrad | S (D) | 150 | $44.44 | 34,301 | Form 4 |
| 2026-08-12 | Derakhshan Behrad | S (D) | 2,475 | $43.7 | 31,826 | Form 4 |
| 2026-08-12 | Derakhshan Behrad | S (D) | 304 | $44.5 | 34,451 | Form 4 |
| 2026-08-12 | Derakhshan Behrad | S (D) | 2,171 | $43.79 | 34,755 | Form 4 |
| 2026-08-12 | Derakhshan Behrad | M (A) | 7,500 | $0 | 36,926 | Form 4 |
| 2026-08-12 | Derakhshan Behrad | M (A) | 5,781 | $0 | 29,426 | Form 4 |
| 2026-08-12 | Russell Alan J | S (D) | 3,238 | $43.68 | 34,129 | Form 4 |
| 2026-08-12 | Russell Alan J | M (A) | 7,031 | $0 | 37,367 | Form 4 |
| 2026-08-12 | Russell Alan J | M (A) | 5,781 | $0 | 30,336 | Form 4 |
| 2026-08-12 | Russell Alan J | S (D) | 390 | $44.46 | 31,466 | Form 4 |
| 2026-08-12 | Russell Alan J | S (D) | 2,273 | $43.68 | 31,856 | Form 4 |
| 2026-07-01 | Russell Alan J | S (D) | 69,648 | $39.41 | 24,555 | Form 4 |
| 2026-07-01 | Russell Alan J | M (A) | 69,648 | $0.18 | 224,555 | Form 4 |
| 2026-07-01 | Russell Alan J | M (A) | 130,352 | $0.45 | 154,907 | Form 4 |
| 2026-07-01 | Russell Alan J | S (D) | 130,352 | $39.41 | 94,203 | Form 4 |
| 2026-07-01 | Fox Jonathan C | A (A) | 319 | $0 | 24,833 | Form 4 |
Transaction codes in this quarter
Get EWTX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1710072&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · EWTX company page · Edgewise Therapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Edgewise Therapeutics, Inc. (EWTX)?
In Q3 2026, insiders at Edgewise Therapeutics, Inc. reported 34 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 21 sales worth $9.8M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Edgewise Therapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/ewtx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.